Regentis Biomaterials
$1.3700
6
+$0.01+0.74%Friday 20:00
+$0.02+1.46%Friday 23:47After hours
Statistics
Day High
1.37
Day Low
1.37
52W High
15.5
52W Low
1.23
Volume
210
Avg. Volume
-
Mkt Cap
9.62M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Financials
-Profit Margin
Unprofitable0Revenue
-13.65MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow RGNT. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing tissue repair solutions that restore health and enhance the quality of life of patients. It is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Gelrin is a hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen (a biologically inactivated protein that normally has a role in blood clotting). Its product is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage.
Show More
CEO
Ehud Geller
Employees
8
Country
Israel
ISIN
IL0012190968
Listings
0 Comments
Share your thoughts
FAQs
What is Regentis Biomaterials stock price today?▼
The current price of RGNT is $1.37 USD — it has increased by +0.74% in the past 24 hours. Watch Regentis Biomaterials stock price performance more closely on the chart.
What is Regentis Biomaterials stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XASE exchange Regentis Biomaterials stocks are traded under the ticker RGNT.
What is Regentis Biomaterials market cap?▼
Today Regentis Biomaterials has the market capitalization of 9.62M
What is Regentis Biomaterials revenue for the last year?▼
Regentis Biomaterials revenue for the last year amounts to 0 USD.
What is Regentis Biomaterials net income for the last year?▼
RGNT net income for the last year is -13.65M USD.
How many employees does Regentis Biomaterials have?▼
As of November 2, 2026, the company has 8 employees.
In which sector is Regentis Biomaterials located?▼
Regentis Biomaterials operates in the Health & Wellness sector.
When did Regentis Biomaterials complete a stock split?▼
Regentis Biomaterials has not had any recent stock splits.
Where is Regentis Biomaterials headquartered?▼
Regentis Biomaterials is headquartered in Herzliya, Israel.